Related references
Note: Only part of the references are listed.COVID-19 in transplant recipients: The Spanish experience
Elisabeth Coll et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients
Anne-Claire Mamez et al.
BONE MARROW TRANSPLANTATION (2021)
Correlates of protection against SARS-CoV-2 in rhesus macaques
Katherine McMahan et al.
NATURE (2021)
Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study
Akshay Sharma et al.
LANCET HAEMATOLOGY (2021)
Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose
Evangelos Terpos et al.
BLOOD (2021)
Vaccinated and Convalescent Donor-Derived Severe Acute Respiratory Syndrome Coronavirus 2-Specific T Cells as Adoptive Immunotherapy for High-Risk Coronavirus Disease 2019 Patients
Penelope-Georgia Papayanni et al.
CLINICAL INFECTIOUS DISEASES (2021)
Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT
Rabah Redjoul et al.
LANCET HAEMATOLOGY (2021)
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
Brian J. Boyarsky et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Exposure to SARS-CoV-2 generates T-cell memory in the absence of a detectable viral infection
Zhongfang Wang et al.
NATURE COMMUNICATIONS (2021)
Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma
Sarah Bird et al.
LANCET HAEMATOLOGY (2021)
Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapy
Binod Dhakal et al.
BLOOD (2021)
Antibody response after second BNT162b2 dose in allogeneic HSCT recipients
Rabah Redjoul et al.
LANCET (2021)
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment
Evangelos Terpos et al.
BLOOD CANCER JOURNAL (2021)
Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study
Paul Naaber et al.
LANCET REGIONAL HEALTH-EUROPE (2021)
Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients
Arne Sattler et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset
Shirin Kalimuddin et al.
MED (2021)
A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction
Chee Wah Tan et al.
NATURE BIOTECHNOLOGY (2020)
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
SARS-CoV-2-specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein
Michael D. Keller et al.
BLOOD (2020)
Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation
Gunjan L. Shah et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)